boston scientific limited

Live MatureMegaHealthy

boston scientific limited Company Information

Share BOSTON SCIENTIFIC LIMITED

Company Number

02729626

Shareholders

boston scientific international bv

Group Structure

View All

Industry

Other human health activities

 +1

Registered Address

breakspear park breakspear way, hemel hempstead, hertfordshire, HP2 4TZ

boston scientific limited Estimated Valuation

£244.2m

Pomanda estimates the enterprise value of BOSTON SCIENTIFIC LIMITED at £244.2m based on a Turnover of £285.3m and 0.86x industry multiple (adjusted for size and gross margin).

boston scientific limited Estimated Valuation

£76.3m

Pomanda estimates the enterprise value of BOSTON SCIENTIFIC LIMITED at £76.3m based on an EBITDA of £10.3m and a 7.42x industry multiple (adjusted for size and gross margin).

boston scientific limited Estimated Valuation

£98.8m

Pomanda estimates the enterprise value of BOSTON SCIENTIFIC LIMITED at £98.8m based on Net Assets of £39.5m and 2.5x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Boston Scientific Limited Overview

Boston Scientific Limited is a live company located in hertfordshire, HP2 4TZ with a Companies House number of 02729626. It operates in the wholesale of other machinery and equipment sector, SIC Code 46690. Founded in July 1992, it's largest shareholder is boston scientific international bv with a 100% stake. Boston Scientific Limited is a mature, mega sized company, Pomanda has estimated its turnover at £285.3m with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Boston Scientific Limited Health Check

Pomanda's financial health check has awarded Boston Scientific Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 7 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3out of 5
positive_score

4 Strong

positive_score

1 Regular

positive_score

7 Weak

size

Size

annual sales of £285.3m, make it larger than the average company (£8.1m)

£285.3m - Boston Scientific Limited

£8.1m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 13%, show it is growing at a faster rate (7.3%)

13% - Boston Scientific Limited

7.3% - Industry AVG

production

Production

with a gross margin of 21.3%, this company has a higher cost of product (32.8%)

21.3% - Boston Scientific Limited

32.8% - Industry AVG

profitability

Profitability

an operating margin of 2.4% make it less profitable than the average company (5.4%)

2.4% - Boston Scientific Limited

5.4% - Industry AVG

employees

Employees

with 443 employees, this is above the industry average (30)

443 - Boston Scientific Limited

30 - Industry AVG

paystructure

Pay Structure

on an average salary of £106.2k, the company has a higher pay structure (£39.1k)

£106.2k - Boston Scientific Limited

£39.1k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £644k, this is more efficient (£209.8k)

£644k - Boston Scientific Limited

£209.8k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 55 days, this is later than average (42 days)

55 days - Boston Scientific Limited

42 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 1 days, this is quicker than average (25 days)

1 days - Boston Scientific Limited

25 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 34 days, this is in line with average (42 days)

34 days - Boston Scientific Limited

42 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (59 weeks)

0 weeks - Boston Scientific Limited

59 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 65.4%, this is a higher level of debt than the average (39.8%)

65.4% - Boston Scientific Limited

39.8% - Industry AVG

BOSTON SCIENTIFIC LIMITED financials

EXPORTms excel logo

Boston Scientific Limited's latest turnover from December 2023 is £285.3 million and the company has net assets of £39.5 million. According to their latest financial statements, Boston Scientific Limited has 443 employees and maintains cash reserves of £288 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover285,301,000247,628,000227,684,000195,578,000226,947,000203,714,000191,615,000186,047,000178,117,328158,557,012142,685,929126,142,689118,744,994123,528,596120,845,708
Other Income Or Grants000000000000000
Cost Of Sales224,446,000197,223,000179,485,000154,531,000178,752,000161,976,000154,288,000141,464,000136,807,790126,271,849112,449,60597,656,03990,855,664101,836,77093,706,658
Gross Profit60,855,00050,405,00048,199,00041,047,00048,195,00041,738,00037,327,00044,583,00041,309,53832,285,16330,236,32428,486,65027,889,33021,691,82627,139,050
Admin Expenses54,001,00043,083,00059,518,00038,953,00044,674,00037,618,00033,701,00042,630,00037,916,90329,772,50130,119,22627,502,90425,534,98426,038,07526,970,110
Operating Profit6,854,0007,322,000-11,319,0002,094,0003,521,0004,120,0003,626,0001,953,0003,392,6352,512,662117,098983,7462,354,346-4,346,249168,940
Interest Payable517,000551,00023,00046,00035,00035,000246,000248,000221,051153,907200,402300,503333,874322,551483,876
Interest Receivable118,00025,0000011,0005,0002,00015,0006,3216,74623,39045,83218,46069,06467,894
Pre-Tax Profit6,706,0006,796,000371,0002,048,0003,497,0004,090,0003,382,0002,422,0003,177,9062,365,501-59,914729,0752,038,932-4,599,736-247,042
Tax-2,619,000-4,795,000-2,375,000-1,014,000-134,000-698,000-716,000-729,000-395,035-550,896-778,335-1,167,029-1,422,984436,451-981,740
Profit After Tax4,087,0002,001,000-2,004,0001,034,0003,363,0003,392,0002,666,0001,693,0002,782,8711,814,605-838,249-437,954615,948-4,163,285-1,228,782
Dividends Paid000000000000000
Retained Profit4,087,0002,001,000-2,004,0001,034,0003,363,0003,392,0002,666,0001,693,0002,782,8711,814,605-838,249-437,954615,948-4,163,285-1,228,782
Employee Costs47,065,00040,842,00039,134,00035,596,00035,047,00030,937,00026,942,00024,436,00021,760,04316,225,59416,203,42613,978,93412,340,90712,211,29112,419,197
Number Of Employees443413397384361330323290261236222208192183175
EBITDA*10,286,00010,261,000-8,913,0005,352,0005,745,0006,281,0005,612,0003,891,0004,329,4893,354,2723,591,0584,494,5725,925,820-604,7003,616,685

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets4,734,0004,244,0004,226,0003,585,0002,923,0002,754,0002,391,0001,743,0001,733,5961,818,3521,653,9151,945,3361,724,5721,788,5531,829,546
Intangible Assets4,773,0005,543,0003,435,0004,492,000988,0001,995,0003,117,0004,239,000326,178441,300556,4212,896,3225,792,6438,688,96511,585,286
Investments & Other21,117,000811,000995,00011,713,00012,682,0000000000000
Debtors (Due After 1 year)000000000000000
Total Fixed Assets30,624,00010,598,0008,656,00019,790,00016,593,0004,749,0005,508,0005,982,0002,059,7742,259,6522,210,3364,841,6587,517,21510,477,51813,414,832
Stock & work in progress21,475,00024,402,00020,109,00020,871,00029,358,00016,944,00023,044,00023,008,00023,838,62021,001,35213,823,63211,071,94012,144,59714,631,8165,847,468
Trade Debtors43,680,00039,182,00030,659,00025,778,00027,449,00031,344,00031,004,00036,077,00026,966,65120,378,84117,510,26615,311,49115,035,36116,619,61114,897,920
Group Debtors8,194,00013,788,00019,336,0009,350,00013,635,00015,352,00013,825,0006,042,0007,696,2209,377,29510,134,1849,341,00014,332,9163,806,95719,442,606
Misc Debtors10,091,0007,931,0007,637,0006,428,0005,046,0003,621,0002,874,0001,896,0001,133,364742,721625,7271,150,8891,220,9471,163,541892,824
Cash288,0003,036,000214,000337,0001,742,000802,000252,00040,000458,039478,0172,350,7701,182,805889,985855,410346,447
misc current assets000000000000000
total current assets83,728,00088,339,00077,955,00062,764,00077,230,00068,063,00070,999,00067,063,00060,092,89451,978,22644,444,57938,058,12543,623,80637,077,33541,427,265
total assets114,352,00098,937,00086,611,00082,554,00093,823,00072,812,00076,507,00073,045,00062,152,66854,237,87846,654,91542,899,78351,141,02147,554,85354,842,097
Bank overdraft000000000000000
Bank loan000000000000000
Trade Creditors 1,210,000339,000380,000590,000853,000459,00089,000123,00028,22893,66429,25577,321599,234166,894116,232
Group/Directors Accounts26,896,00019,729,00018,339,00010,335,00031,920,00016,123,00025,976,00028,399,00026,290,64517,294,8847,755,39623,725,34410,025,5469,367,92314,145,701
other short term finances0000000009,000,00013,690,0000000
hp & lease commitments313,000153,000160,000000000000000
other current liabilities45,330,00044,488,00036,936,00041,122,00033,011,00032,848,00031,583,00029,509,00024,162,19720,113,68519,522,57913,026,31911,114,0579,879,5108,751,701
total current liabilities73,749,00064,709,00055,815,00052,047,00065,784,00049,430,00057,648,00058,031,00050,481,07046,502,23340,997,23036,828,98421,738,83719,414,32723,013,634
loans00000000000023,223,40023,223,40023,223,400
hp & lease commitments000000000000000
Accruals and Deferred Income000000000000000
other liabilities1,056,000659,000835,000000000000000
provisions000000000000000
total long term liabilities1,056,000659,000835,00000000000023,223,40023,223,40023,223,400
total liabilities74,805,00065,368,00056,650,00052,047,00065,784,00049,430,00057,648,00058,031,00050,481,07046,502,23340,997,23036,828,98444,962,23742,637,72746,237,034
net assets39,547,00033,569,00029,961,00030,507,00028,039,00023,382,00018,859,00015,014,00011,671,5987,735,6455,657,6856,070,7996,178,7844,917,1268,605,063
total shareholders funds39,547,00033,569,00029,961,00030,507,00028,039,00023,382,00018,859,00015,014,00011,671,5987,735,6455,657,6856,070,7996,178,7844,917,1268,605,063
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit6,854,0007,322,000-11,319,0002,094,0003,521,0004,120,0003,626,0001,953,0003,392,6352,512,662117,098983,7462,354,346-4,346,249168,940
Depreciation1,685,0001,594,0001,349,0001,478,0001,217,0001,039,000864,000816,000821,733726,489558,451614,504675,152845,228551,423
Amortisation1,747,0001,345,0001,057,0001,780,0001,007,0001,122,0001,122,0001,122,000115,121115,1212,915,5092,896,3222,896,3222,896,3212,896,322
Tax-2,619,000-4,795,000-2,375,000-1,014,000-134,000-698,000-716,000-729,000-395,035-550,896-778,335-1,167,029-1,422,984436,451-981,740
Stock-2,927,0004,293,000-762,000-8,487,00012,414,000-6,100,00036,000-830,6202,837,2687,177,7202,751,692-1,072,657-2,487,2198,784,3485,847,468
Debtors1,064,0003,269,00016,076,000-4,574,000-4,187,0002,614,0003,688,0008,218,7655,297,3782,228,6802,466,797-4,785,8448,999,115-13,643,24135,233,350
Creditors871,000-41,000-210,000-263,000394,000370,000-34,00094,772-65,43664,409-48,066-521,913432,34050,662116,232
Accruals and Deferred Income842,0007,552,000-4,186,0008,111,000163,0001,265,0002,074,0005,346,8034,048,512591,1066,496,2601,912,2621,234,5471,127,8098,751,701
Deferred Taxes & Provisions000000000000000
Cash flow from operations11,243,0005,415,000-30,998,00025,247,000-2,059,00010,704,0003,212,0001,215,430-217,116-5,947,5094,042,42810,576,393-342,1735,869,115-29,577,940
Investing Activities
capital expenditure-3,152,000-5,065,000-1,990,000-7,424,000-1,386,000-1,402,000-1,512,000-5,860,226-736,976-890,926-842,638-835,269-611,171-804,235-16,862,577
Change in Investments20,306,000-184,000-10,718,000-969,00012,682,0000000000000
cash flow from investments-23,458,000-4,881,0008,728,000-6,455,000-14,068,000-1,402,000-1,512,000-5,860,226-736,976-890,926-842,638-835,269-611,171-804,235-16,862,577
Financing Activities
Bank loans000000000000000
Group/Directors Accounts7,167,0001,390,0008,004,000-21,585,00015,797,000-9,853,000-2,423,0002,108,3558,995,7619,539,488-15,969,94813,699,798657,623-4,777,77814,145,701
Other Short Term Loans 00000000-9,000,000-4,690,00013,690,0000000
Long term loans00000000000-23,223,4000023,223,400
Hire Purchase and Lease Commitments160,000-7,000160,000000000000000
other long term liabilities397,000-176,000835,000000000000000
share issue1,891,0001,607,0001,458,0001,434,0001,294,0001,131,0001,179,0001,649,4021,153,082263,355425,135329,969645,710475,3489,833,845
interest-399,000-526,000-23,000-46,000-24,000-30,000-244,000-233,000-214,730-147,161-177,012-254,671-315,414-253,487-415,982
cash flow from financing9,216,0002,288,00010,434,000-20,197,00017,067,000-8,752,000-1,488,0003,524,757934,1134,965,682-2,031,825-9,448,304987,919-4,555,91746,786,964
cash and cash equivalents
cash-2,748,0002,822,000-123,000-1,405,000940,000550,000212,000-418,039-19,978-1,872,7531,167,965292,82034,575508,963346,447
overdraft000000000000000
change in cash-2,748,0002,822,000-123,000-1,405,000940,000550,000212,000-418,039-19,978-1,872,7531,167,965292,82034,575508,963346,447

boston scientific limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for boston scientific limited. Get real-time insights into boston scientific limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Boston Scientific Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for boston scientific limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mega companies, companies in HP2 area or any other competitors across 12 key performance metrics.

boston scientific limited Ownership

BOSTON SCIENTIFIC LIMITED group structure

Boston Scientific Limited has 2 subsidiary companies.

Ultimate parent company

BOSTON SCIENTIFIC CORP

#0018473

BOSTON SCIENTIFIC INTERNATIONAL BV

#0016829

2 parents

BOSTON SCIENTIFIC LIMITED

02729626

2 subsidiaries

BOSTON SCIENTIFIC LIMITED Shareholders

boston scientific international bv 100%

boston scientific limited directors

Boston Scientific Limited currently has 3 directors. The longest serving directors include Ms Julie Zeiler (Mar 2010) and Jonathan Monson (Oct 2019).

officercountryagestartendrole
Ms Julie ZeilerFrance59 years Mar 2010- Director
Jonathan MonsonUnited States51 years Oct 2019- Director
Ms Emily WoodworthUnited States47 years Aug 2024- Director

P&L

December 2023

turnover

285.3m

+15%

operating profit

6.9m

-6%

gross margin

21.4%

+4.79%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

39.5m

+0.18%

total assets

114.4m

+0.16%

cash

288k

-0.91%

net assets

Total assets minus all liabilities

boston scientific limited company details

company number

02729626

Type

Private limited with Share Capital

industry

86900 - Other human health activities

46690 - Wholesale of other machinery and equipment

incorporation date

July 1992

age

33

incorporated

UK

ultimate parent company

BOSTON SCIENTIFIC CORP

accounts

Full Accounts

last accounts submitted

December 2023

previous names

bestdane limited (July 1992)

accountant

-

auditor

ERNST & YOUNG LLP

address

breakspear park breakspear way, hemel hempstead, hertfordshire, HP2 4TZ

Bank

DEUTSCHE BANK AG

Legal Advisor

BAKER & MCKENZIE

boston scientific limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 2 charges/mortgages relating to boston scientific limited. Currently there are 2 open charges and 0 have been satisfied in the past.

boston scientific limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for BOSTON SCIENTIFIC LIMITED. This can take several minutes, an email will notify you when this has completed.

boston scientific limited Companies House Filings - See Documents

datedescriptionview/download